Tracheal fistula associated with bevacizumab 20 months after mediastinal radiation

BMJ Case Rep. 2010 Nov 29:2010:bcr0820103284. doi: 10.1136/bcr.08.2010.3284.

Authors

Hideto Yamada¹, Wataru Shigemori, Yasushi Ryujin, Hiroshi Wada, Tetsuya Oguma, Makoto Osawa, Taishi Nagao, Yasutaka Nakano

Affiliation

¹ Department of Internal Medicine, Division of Respiratory Medicine, Shiga University of Medical Science, Seta Tsukinowa-cho, Otsu, Japan. otedih@belle.shiga-med.ac.jp

No abstract available

Publication types

Case Reports

MeSH terms

Adenocarcinoma / pathology
Adenocarcinoma / therapy*
Aged
Angiogenesis Inhibitors / administration & dosage
Angiogenesis Inhibitors / adverse effects*
Antibodies, Monoclonal, Humanized / administration & dosage
Antibodies, Monoclonal, Humanized / adverse effects*
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Bevacizumab
Chemoradiotherapy / adverse effects*
Disease Progression
Fatal Outcome
Female
Fistula / chemically induced*
Fistula / diagnosis*
Follow-Up Studies
Humans
Image Interpretation, Computer-Assisted
Lung Neoplasms / pathology
Lung Neoplasms / therapy*
Neoplasm Recurrence, Local / pathology
Neoplasm Recurrence, Local / therapy*
Neoplasm Staging
Radiation Injuries / diagnosis*
Tomography, X-Ray Computed
Tracheal Diseases / chemically induced*
Tracheal Diseases / diagnosis*

Substances

Angiogenesis Inhibitors
Antibodies, Monoclonal, Humanized
Bevacizumab